Polychlorinated biphenyls (PCBs) have been associated with abnormal liver enzymes and suspected nonalcoholic fatty liver disease (NAFLD) in cohort studies. NAFLD affects greater than 25% of the global population and may result in liver-related mortality. Both dioxin-like and non-dioxin-like PCBs have been associated with NAFLD, but their effects and mechanisms differ. Dioxin-like PCBs altered the gut:liver axis and microbiome and caused hepatic steatosis by disrupting hepatic lipid metabolism. In contrast, NDL PCBs reduced the liver's protective responses to promote diet-induced NAFLD. Mechanisms included the disruption of phosphoprotein signaling resulting in altered nuclear receptor function.
Polychlorinated Biphenyls and Nonalcoholic Fatty Liver Disease.
B. Wahlang,Josiah E. Hardesty,Jian-Kang Jin,K. Falkner,M. Cave
Published 2019 in Current Opinion in Toxicology
ABSTRACT
PUBLICATION RECORD
- Publication year
2019
- Venue
Current Opinion in Toxicology
- Publication date
2019-04-01
- Fields of study
Medicine, Environmental Science
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-48 of 48 references · Page 1 of 1
CITED BY
Showing 1-51 of 51 citing papers · Page 1 of 1